Phase III trial comparing epirubicin/paclitaxel vs epirubicin/cyclophosphamid as first line treatment in metastatic breast cancer: Preliminary results of a German AGO trial
Keyword(s):
2007 ◽
Vol 41
(6)
◽
pp. 555-562
◽
Keyword(s):
Keyword(s):
2015 ◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 1041-1041
Keyword(s):
2012 ◽
2009 ◽
Vol 7
(2)
◽
pp. 265
◽
Keyword(s):
1999 ◽
Vol 35
◽
pp. S315
◽
Keyword(s):
Keyword(s):
2005 ◽
Vol 16
(8)
◽
pp. 871-877
◽
2020 ◽
Keyword(s):